MARIA, NCT05219734: MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment |
|
|
| Active, not recruiting | N/A | 400 | US | Personalized Cancer Monitoring (PCM) | Invitae Corporation | Cancer, Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, Bladder Cancer | 12/26 | 12/26 | | |